Revvity, Inc. Logo

Revvity, Inc.

RVTY

(1.5)
Stock Price

112,56 USD

4.71% ROA

3.52% ROE

77.92x PER

Market Cap.

15.050.814.110,00 USD

49.22% DER

0.23% Yield

10.18% NPM

Revvity, Inc. Stock Analysis

Revvity, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Revvity, Inc. Fundamental Stock Analysis
# Analysis Rating
1 ROE

The stock's ROE falls within an average range (3.34%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.

2 ROA

The stock's ROA (5.62%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.

3 PBV

The stock's PBV ratio (1.4x) indicates a justifiable valuation, presenting a compelling choice for investors seeking reasonable returns.

4 DER

The stock maintains a fair debt to equity ratio (57%), indicating a reasonable balance between the money it owes and the ownership it possesses.

5 Dividend

Investors can take comfort in the fact that the company has consistently distributed dividends over the past three years, demonstrating a commitment to rewarding shareholders.

6 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is undervalued (1.285), making it an appealing investment prospect with its intrinsic value surpassing the current market price.

7 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

8 Net Profit Growth

Despite the passage of five years, this company's net profit has not shown any improvement, highlighting a lack of growth and making it a less appealing investment prospect.

9 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

10 Graham Number

The Graham number of this company suggests that its stock price may be overvalued, indicating a less favorable investment opportunity.

11 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

Revvity, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Revvity, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Sell
4 Stoch RSI Sell

Revvity, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Revvity, Inc. Revenue
Year Revenue Growth
1985 1.155.100.000
1986 1.145.100.000 -0.87%
1987 1.235.900.000 7.35%
1988 1.406.300.000 12.12%
1989 1.650.200.000 14.78%
1990 2.474.300.000 33.31%
1991 2.688.500.000 7.97%
1992 2.788.800.000 3.6%
1993 2.697.900.000 -3.37%
1994 1.332.600.000 -102.45%
1995 1.419.600.000 6.13%
1996 1.427.300.000 0.54%
1997 1.460.800.000 2.29%
1998 1.407.900.000 -3.76%
1999 1.363.100.000 -3.29%
2000 1.695.267.000 19.59%
2001 1.330.054.000 -27.46%
2002 1.504.981.000 11.62%
2003 1.535.222.000 1.97%
2004 1.687.231.000 9.01%
2005 1.473.831.000 -14.48%
2006 1.546.358.000 4.69%
2007 1.787.331.000 13.48%
2008 1.937.465.000 7.75%
2009 1.812.202.000 -6.91%
2010 1.704.346.000 -6.33%
2011 1.921.287.000 11.29%
2012 2.115.205.000 9.17%
2013 2.166.232.000 2.36%
2014 2.237.219.000 3.17%
2015 2.262.359.000 1.11%
2016 2.115.517.000 -6.94%
2017 2.256.982.000 6.27%
2018 2.777.996.000 18.76%
2019 2.883.673.000 3.66%
2020 3.782.745.000 23.77%
2021 5.067.169.000 25.35%
2022 3.311.822.000 -53%
2023 2.682.956.000 -23.44%
2023 2.750.571.000 2.46%
2024 2.766.740.000 0.58%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Revvity, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
1985 0
1986 0 0%
1987 0 0%
1988 0 0%
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 44.900.000 100%
1998 46.000.000 2.39%
1999 71.200.000 35.39%
2000 86.117.000 17.32%
2001 81.315.000 -5.91%
2002 86.451.000 5.94%
2003 83.145.000 -3.98%
2004 87.050.000 4.49%
2005 87.371.000 0.37%
2006 99.719.000 12.38%
2007 111.619.000 10.66%
2008 108.062.000 -3.29%
2009 107.251.000 -0.76%
2010 95.409.000 -12.41%
2011 115.821.000 17.62%
2012 132.639.000 12.68%
2013 133.023.000 0.29%
2014 121.141.000 -9.81%
2015 125.928.000 3.8%
2016 124.278.000 -1.33%
2017 139.404.000 10.85%
2018 193.998.000 28.14%
2019 189.336.000 -2.46%
2020 205.389.000 7.82%
2021 274.969.000 25.3%
2022 221.617.000 -24.07%
2023 212.156.000 -4.46%
2023 216.578.000 2.04%
2024 192.528.000 -12.49%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Revvity, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
1985 0
1986 0 0%
1987 0 0%
1988 0 0%
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 1.014.220.000 100%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Revvity, Inc. EBITDA
Year EBITDA Growth
1985 79.000.000
1986 57.200.000 -38.11%
1987 91.500.000 37.49%
1988 115.800.000 20.98%
1989 113.400.000 -2.12%
1990 127.600.000 11.13%
1991 154.900.000 17.62%
1992 154.300.000 -0.39%
1993 151.300.000 -1.98%
1994 168.000.000 9.94%
1995 118.700.000 -41.53%
1996 135.900.000 12.66%
1997 166.200.000 18.23%
1998 82.100.000 -102.44%
1999 243.900.000 66.34%
2000 311.284.000 21.65%
2001 281.843.000 -10.45%
2002 219.477.000 -28.42%
2003 273.687.000 19.81%
2004 266.584.000 -2.66%
2005 358.671.000 25.67%
2006 220.238.000 -62.86%
2007 271.670.000 18.93%
2008 318.067.000 14.59%
2009 260.722.000 -21.99%
2010 262.559.000 0.7%
2011 218.965.000 -19.91%
2012 322.529.000 32.11%
2013 372.386.000 13.39%
2014 335.999.000 -10.83%
2015 407.609.000 17.57%
2016 385.130.000 -5.84%
2017 458.624.000 16.02%
2018 503.547.000 8.92%
2019 579.232.000 13.07%
2020 1.210.596.000 52.15%
2021 1.745.465.000 30.64%
2022 1.198.546.000 -45.63%
2023 791.756.000 -51.38%
2023 732.331.000 -8.11%
2024 835.072.000 12.3%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Revvity, Inc. Gross Profit
Year Gross Profit Growth
1985 227.200.000
1986 209.800.000 -8.29%
1987 251.900.000 16.71%
1988 292.000.000 13.73%
1989 303.800.000 3.88%
1990 333.500.000 8.91%
1991 382.000.000 12.7%
1992 401.500.000 4.86%
1993 393.200.000 -2.11%
1994 374.800.000 -4.91%
1995 407.000.000 7.91%
1996 419.500.000 2.98%
1997 420.700.000 0.29%
1998 416.600.000 -0.98%
1999 575.800.000 27.65%
2000 776.840.000 25.88%
2001 608.329.000 -27.7%
2002 600.881.000 -1.24%
2003 628.953.000 4.46%
2004 680.553.000 7.58%
2005 614.536.000 -10.74%
2006 628.071.000 2.16%
2007 724.740.000 13.34%
2008 830.105.000 12.69%
2009 779.794.000 -6.45%
2010 758.631.000 -2.79%
2011 850.579.000 10.81%
2012 963.206.000 11.69%
2013 976.974.000 1.41%
2014 1.004.608.000 2.75%
2015 1.024.500.000 1.94%
2016 1.013.353.000 -1.1%
2017 1.073.031.000 5.56%
2018 1.340.939.000 19.98%
2019 1.396.055.000 3.95%
2020 2.109.877.000 33.83%
2021 2.851.300.000 26%
2022 1.989.830.000 -43.29%
2023 1.490.064.000 -33.54%
2023 1.174.578.000 -26.86%
2024 1.542.024.000 23.83%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Revvity, Inc. Net Profit
Year Net Profit Growth
1985 55.700.000
1986 44.900.000 -24.05%
1987 55.500.000 19.1%
1988 68.700.000 19.21%
1989 69.900.000 1.72%
1990 74.000.000 5.54%
1991 81.200.000 8.87%
1992 87.800.000 7.52%
1993 79.600.000 -10.3%
1994 -32.100.000 347.98%
1995 54.300.000 159.12%
1996 60.200.000 9.8%
1997 33.700.000 -78.64%
1998 102.000.000 66.96%
1999 28.400.000 -259.15%
2000 90.520.000 68.63%
2001 -620.000 14700%
2002 -4.135.000 85.01%
2003 52.959.000 107.81%
2004 96.043.000 44.86%
2005 66.532.000 -44.36%
2006 119.583.000 44.36%
2007 131.686.000 9.19%
2008 126.409.000 -4.17%
2009 85.599.000 -47.68%
2010 135.922.000 37.02%
2011 174.000 -78016.09%
2012 69.940.000 99.75%
2013 167.212.000 58.17%
2014 157.778.000 -5.98%
2015 212.425.000 25.73%
2016 234.299.000 9.34%
2017 156.890.000 -49.34%
2018 237.927.000 34.06%
2019 227.558.000 -4.56%
2020 727.887.000 68.74%
2021 943.157.000 22.82%
2022 569.179.000 -65.7%
2023 37.988.000 -1398.31%
2023 179.503.000 78.84%
2024 316.436.000 43.27%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Revvity, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1985 1
1986 0 0%
1987 1 0%
1988 1 0%
1989 1 0%
1990 1 0%
1991 1 0%
1992 1 0%
1993 1 0%
1994 0 0%
1995 1 0%
1996 1 0%
1997 0 0%
1998 1 100%
1999 0 0%
2000 1 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 1 0%
2005 1 0%
2006 1 0%
2007 1 100%
2008 1 0%
2009 1 0%
2010 1 100%
2011 0 0%
2012 1 0%
2013 1 100%
2014 1 0%
2015 2 0%
2016 2 50%
2017 1 -100%
2018 2 50%
2019 2 0%
2020 7 66.67%
2021 8 25%
2022 5 -100%
2023 0 0%
2023 1 100%
2024 3 50%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Revvity, Inc. Free Cashflow
Year Free Cashflow Growth
1989 29.100.000
1990 109.400.000 73.4%
1991 77.800.000 -40.62%
1992 105.400.000 26.19%
1993 84.200.000 -25.18%
1994 58.600.000 -43.69%
1995 88.400.000 33.71%
1996 -300.000 29566.67%
1997 -13.900.000 97.84%
1998 -194.900.000 92.87%
1999 -227.600.000 14.37%
2000 74.950.000 403.67%
2001 34.600.000 -116.62%
2002 33.685.000 -2.72%
2003 149.928.000 77.53%
2004 181.796.000 17.53%
2005 183.042.000 0.68%
2006 82.967.000 -120.62%
2007 158.149.000 47.54%
2008 174.519.000 9.38%
2009 117.036.000 -49.12%
2010 130.607.000 10.39%
2011 194.282.000 32.77%
2012 109.762.000 -77%
2013 119.600.000 8.23%
2014 252.525.000 52.64%
2015 257.466.000 1.92%
2016 318.913.000 19.27%
2017 249.364.000 -27.89%
2018 217.785.000 -14.5%
2019 282.138.000 22.81%
2020 814.671.000 65.37%
2021 1.310.862.000 37.85%
2022 594.178.000 -120.62%
2023 -55.842.000 1164.03%
2023 9.904.000 663.83%
2024 136.590.000 92.75%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Revvity, Inc. Operating Cashflow
Year Operating Cashflow Growth
1989 52.400.000
1990 129.200.000 59.44%
1991 104.400.000 -23.75%
1992 127.800.000 18.31%
1993 112.100.000 -14.01%
1994 95.900.000 -16.89%
1995 150.200.000 36.15%
1996 80.200.000 -87.28%
1997 34.800.000 -130.46%
1998 69.600.000 50%
1999 115.800.000 39.9%
2000 145.548.000 20.44%
2001 123.299.000 -18.04%
2002 101.504.000 -21.47%
2003 167.475.000 39.39%
2004 200.757.000 16.58%
2005 208.093.000 3.53%
2006 127.440.000 -63.29%
2007 205.127.000 37.87%
2008 217.844.000 5.84%
2009 148.722.000 -46.48%
2010 164.253.000 9.46%
2011 224.874.000 26.96%
2012 152.170.000 -47.78%
2013 158.591.000 4.05%
2014 281.597.000 43.68%
2015 287.098.000 1.92%
2016 350.615.000 18.12%
2017 288.453.000 -21.55%
2018 311.038.000 7.26%
2019 363.469.000 14.43%
2020 892.177.000 59.26%
2021 1.410.750.000 36.76%
2022 679.810.000 -107.52%
2023 -33.485.000 2130.19%
2023 91.272.000 136.69%
2024 158.621.000 42.46%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Revvity, Inc. Capital Expenditure
Year Capital Expenditure Growth
1989 23.300.000
1990 19.800.000 -17.68%
1991 26.600.000 25.56%
1992 22.400.000 -18.75%
1993 27.900.000 19.71%
1994 37.300.000 25.2%
1995 61.800.000 39.64%
1996 80.500.000 23.23%
1997 48.700.000 -65.3%
1998 264.500.000 81.59%
1999 343.400.000 22.98%
2000 70.598.000 -386.42%
2001 88.699.000 20.41%
2002 67.819.000 -30.79%
2003 17.547.000 -286.5%
2004 18.961.000 7.46%
2005 25.051.000 24.31%
2006 44.473.000 43.67%
2007 46.978.000 5.33%
2008 43.325.000 -8.43%
2009 31.686.000 -36.73%
2010 33.646.000 5.83%
2011 30.592.000 -9.98%
2012 42.408.000 27.86%
2013 38.991.000 -8.76%
2014 29.072.000 -34.12%
2015 29.632.000 1.89%
2016 31.702.000 6.53%
2017 39.089.000 18.9%
2018 93.253.000 58.08%
2019 81.331.000 -14.66%
2020 77.506.000 -4.94%
2021 99.888.000 22.41%
2022 85.632.000 -16.65%
2023 22.357.000 -283.02%
2023 81.368.000 72.52%
2024 22.031.000 -269.33%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Revvity, Inc. Equity
Year Equity Growth
1985 203.400.000
1986 236.300.000 13.92%
1987 271.400.000 12.93%
1988 332.300.000 18.33%
1989 349.000.000 4.79%
1990 369.600.000 5.57%
1991 420.700.000 12.15%
1992 473.600.000 11.17%
1993 477.500.000 0.82%
1994 445.400.000 -7.21%
1995 366.900.000 -21.4%
1996 365.100.000 -0.49%
1997 328.300.000 -11.21%
1998 399.700.000 17.86%
1999 550.800.000 27.43%
2000 728.389.000 24.38%
2001 1.363.557.000 46.58%
2002 1.252.344.000 -8.88%
2003 1.349.050.000 7.17%
2004 1.460.085.000 7.6%
2005 1.650.513.000 11.54%
2006 1.577.730.000 -4.61%
2007 1.575.277.000 -0.16%
2008 1.567.943.000 -0.47%
2009 1.628.957.000 3.75%
2010 1.925.818.000 15.41%
2011 1.841.218.000 -4.59%
2012 1.939.812.000 5.08%
2013 1.992.086.000 2.62%
2014 2.042.102.000 2.45%
2015 2.110.441.000 3.24%
2016 2.153.570.000 2%
2017 2.503.188.000 13.97%
2018 2.584.955.000 3.16%
2019 2.813.824.000 8.13%
2020 3.735.492.000 24.67%
2021 7.130.245.000 47.61%
2022 7.392.876.000 3.55%
2023 7.694.281.000 3.92%
2023 7.872.739.000 2.27%
2024 7.870.314.000 -0.03%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Revvity, Inc. Assets
Year Assets Growth
1985 429.800.000
1986 445.200.000 3.46%
1987 515.500.000 13.64%
1988 539.300.000 4.41%
1989 643.400.000 16.18%
1990 675.200.000 4.71%
1991 697.900.000 3.25%
1992 749.700.000 6.91%
1993 768.800.000 2.48%
1994 793.100.000 3.06%
1995 803.900.000 1.34%
1996 822.900.000 2.31%
1997 832.100.000 1.11%
1998 1.184.900.000 29.77%
1999 1.714.600.000 30.89%
2000 2.260.179.000 24.14%
2001 2.919.129.000 22.57%
2002 2.836.239.000 -2.92%
2003 2.607.719.000 -8.76%
2004 2.575.507.000 -1.25%
2005 2.693.461.000 4.38%
2006 2.510.322.000 -7.3%
2007 2.949.337.000 14.89%
2008 2.931.767.000 -0.6%
2009 3.064.242.000 4.32%
2010 3.209.373.000 4.52%
2011 3.838.687.000 16.39%
2012 3.901.762.000 1.62%
2013 3.946.712.000 1.14%
2014 4.134.526.000 4.54%
2015 4.139.173.000 0.11%
2016 4.276.683.000 3.22%
2017 6.091.573.000 29.79%
2018 5.975.472.000 -1.94%
2019 6.544.565.000 8.7%
2020 8.010.286.000 18.3%
2021 15.015.554.000 46.65%
2022 14.126.851.000 -6.29%
2023 13.421.548.000 -5.26%
2023 13.564.665.000 1.06%
2024 13.424.849.000 -1.04%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Revvity, Inc. Liabilities
Year Liabilities Growth
1985 226.400.000
1986 208.900.000 -8.38%
1987 244.100.000 14.42%
1988 207.000.000 -17.92%
1989 294.400.000 29.69%
1990 305.600.000 3.66%
1991 277.200.000 -10.25%
1992 276.100.000 -0.4%
1993 291.300.000 5.22%
1994 347.700.000 16.22%
1995 437.000.000 20.43%
1996 457.800.000 4.54%
1997 503.800.000 9.13%
1998 785.200.000 35.84%
1999 1.163.800.000 32.53%
2000 1.531.790.000 24.02%
2001 1.555.572.000 1.53%
2002 1.583.895.000 1.79%
2003 1.258.669.000 -25.84%
2004 1.115.422.000 -12.84%
2005 1.042.948.000 -6.95%
2006 932.592.000 -11.83%
2007 1.374.060.000 32.13%
2008 1.363.824.000 -0.75%
2009 1.435.285.000 4.98%
2010 1.283.555.000 -11.82%
2011 1.997.469.000 35.74%
2012 1.961.950.000 -1.81%
2013 1.954.626.000 -0.37%
2014 2.092.424.000 6.59%
2015 2.028.732.000 -3.14%
2016 2.123.113.000 4.45%
2017 3.588.385.000 40.83%
2018 3.390.517.000 -5.84%
2019 3.730.741.000 9.12%
2020 4.274.794.000 12.73%
2021 7.885.309.000 45.79%
2022 6.733.975.000 -17.1%
2023 5.727.267.000 -17.58%
2023 5.691.926.000 -0.62%
2024 5.554.535.000 -2.47%

Revvity, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
21.96
Net Income per Share
1.57
Price to Earning Ratio
77.92x
Price To Sales Ratio
5.56x
POCF Ratio
32.07
PFCF Ratio
39.3
Price to Book Ratio
1.91
EV to Sales
6.57
EV Over EBITDA
24.01
EV to Operating CashFlow
37.93
EV to FreeCashFlow
46.48
Earnings Yield
0.01
FreeCashFlow Yield
0.03
Market Cap
15,05 Bil.
Enterprise Value
17,80 Bil.
Graham Number
47.42
Graham NetNet
-23.93

Income Statement Metrics

Net Income per Share
1.57
Income Quality
2.38
ROE
0.02
Return On Assets
0.02
Return On Capital Employed
0.03
Net Income per EBT
1.1
EBT Per Ebit
0.79
Ebit per Revenue
0.12
Effective Tax Rate
-0.02

Margins

Sales, General, & Administrative to Revenue
0.28
Research & Developement to Revenue
0.07
Stock Based Compensation to Revenue
0.01
Gross Profit Margin
0.49
Operating Profit Margin
0.12
Pretax Profit Margin
0.09
Net Profit Margin
0.1

Dividends

Dividend Yield
0
Dividend Yield %
0.23
Payout Ratio
0.18
Dividend Per Share
0.28

Operating Metrics

Operating Cashflow per Share
3.8
Free CashFlow per Share
3.1
Capex to Operating CashFlow
0.18
Capex to Revenue
0.03
Capex to Depreciation
0.2
Return on Invested Capital
0.02
Return on Tangible Assets
0.05
Days Sales Outstanding
80.52
Days Payables Outstanding
45.83
Days of Inventory on Hand
105.22
Receivables Turnover
4.53
Payables Turnover
7.96
Inventory Turnover
3.47
Capex per Share
0.7

Balance Sheet

Cash per Share
15,84
Book Value per Share
63,80
Tangible Book Value per Share
-11.77
Shareholders Equity per Share
63.8
Interest Debt per Share
32.21
Debt to Equity
0.49
Debt to Assets
0.29
Net Debt to EBITDA
3.71
Current Ratio
2.27
Tangible Asset Value
-1,45 Bil.
Net Current Asset Value
-2,40 Bil.
Invested Capital
11738042000
Working Capital
1,77 Bil.
Intangibles to Total Assets
0.69
Average Receivables
0,59 Bil.
Average Payables
0,18 Bil.
Average Inventory
407730500
Debt to Market Cap
0.26

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Revvity, Inc. Dividends
Year Dividends Growth
1983 0
1984 0 0%
1985 0 0%
1986 1 0%
1987 1 0%
1988 1 0%
1989 1 0%
1990 1 0%
1991 1 0%
1992 1 0%
1993 1 0%
1994 1 0%
1995 1 0%
1996 1 0%
1997 1 0%
1998 1 0%
1999 1 0%
2000 1 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

Revvity, Inc. Profile

About Revvity, Inc.

Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection, and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

CEO
Dr. Prahlad R. Singh Ph.D.
Employee
11.000
Address
940 Winter Street
Waltham, 02451

Revvity, Inc. Executives & BODs

Revvity, Inc. Executives & BODs
# Name Age
1 Mr. Stephen Barr Willoughby
Senior Vice President of Investor Relations & Head of ESG
70
2 Mr. Tajinder S. Vohra
Senior Vice President of Global Operations
70
3 Ms. Magali Four
Senior Vice President and Chief People & Culture Officer
70
4 Mr. Maxwell Krakowiak
Senior Vice President & Chief Financial Officer
70
5 Ms. Miriame Victor
Senior Vice President & Chief Commercial Officer
70
6 Mr. Bryan A. Kipp
Senior Vice President of Technology & Licensing
70
7 Dr. Prahlad R. Singh Ph.D.
Chief Executive Officer, President & Director
70
8 Mr. Joel S. Goldberg
Senior Vice President of Administration, General Counsel & Secretary
70
9 Mr. Andrew Okun
Vice President, Chief Accounting Officer & Treasurer
70
10 Ms. Madhuri Hegde FACMG, Ph.D.
Senior Vice President & Chief Scientific Officer
70

Revvity, Inc. Competitors